Skip to content

Omentectomy in Radical Gastrectomy for Gastric Cancer Trial

Omentectomy in Radical Gastrectomy for Gastric Cancer Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02050659
Acronym
OMEGA
Enrollment
100
Registered
2014-01-31
Start date
2012-03-31
Completion date
2014-02-28
Last updated
2015-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Omentum, Stomach Neoplasms

Brief summary

In patients with gastric cancer, traditionally a complete omentectomy is performed as part of a radical gastrectomy with a modified D2 lymph node dissection. The omentectomy increases operation time significantly, especially in laparoscopic procedures. Patients remain more vulnerable for peritoneal infections and intestinal adhesions following omentectomy. Furthermore one can debate whether a complete omentectomy is indicated from an oncologic viewpoint. In the present study we prospectively evaluated the presence of tumor load in the greater omentum of patients with potentially curative gastric cancer.

Interventions

None listed

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* an in potentially curative gastric cancer * age \> 18 year

Exclusion criteria

* palliative resection * age \< 18 year

Design outcomes

Primary

MeasureTime frame
tumorload in the greater omentumat the time of pathologic investigation

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026